Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Eradication of latent Epstein-Barr virus by hydroxyurea alters the growth-transformed cell phenotype.

The Journal of infectious diseases - 1 May 1998

Chodosh J, Holder V P, Gan Y J, Belgaumi A, Sample J, Sixbey J W

Abstract excerpt

The hallmark of infection by human herpesviruses, life-long persistence in the host, is unaffected by current antiviral therapies effective against replication of virus. In vitro studies indicated that low concentrations of the ribonucleotide reductase inhibitor, hydroxyurea, completely eliminate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Division
Share to Cell Line
Share to Cell Transformation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clone Cells

Share to DNA, Viral

Share to Phenotype

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 9593003
DOI: 10.1086/515290

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-9593003-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Eradication of latent Epstein-Barr virus by hydroxyurea alters the growth-transformed cell phenotype.PMID 9593003Read ↗

Eradication of Epstein-Barr virus episome and associated inhibition of infected tumor cell growth by adenovirus vector-mediated transduction of dominant-negative EBNA1.Semantic proximity Read ↗

Immortalization of human primary B lymphocytes in vitro with DNA.Semantic proximity Read ↗

The targeting of primary effusion lymphoma cells for apoptosis by inducing lytic replication of human herpesvirus 8 while blocking virus productionSemantic proximity Read ↗

The Cell Killing Mechanisms of HydroxyureaSemantic proximity Read ↗

Limited nucleotide pools restrict Epstein–Barr virus-mediated B-cell immortalizationSemantic proximity Read ↗

Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells.Semantic proximity Read ↗

Circulating human B lymphocytes are deficient in nucleotide excision repair and accumulate mutations upon proliferation.Semantic proximity Read ↗

Immortalization of human lymphocytes by Epstein-Barr virus.Semantic proximity Read ↗

Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNASemantic proximity Read ↗

Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathwaySemantic proximity Read ↗

Replication of wild-type and mutant human cytomegalovirus in life-extended human diploid fibroblasts.Semantic proximity Read ↗

Requirement for Uracil-DNA Glycosylase during the Transition to Late-Phase Cytomegalovirus DNA ReplicationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.